Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global ...

Chinese biotech companies, led by Frontier Biotechnologies, signed major cross-border licensing deals in 2026 focused on small nucleic acid (siRNA) drugs, with deals totaling over $36 billion in 2025.

Nucleic acids are complex biological molecules that store and transmit genetic information in all living organisms. They are essential for the survival and reproduction of life on Earth. The two main ...

Viral diseases pose a significant global health challenge, placing substantial strain on healthcare systems. Accurate identification of viral infections is crucial for monitoring outbreaks, managing ...

Nucleic acid technology came of age during COVID-19 with biopharma firms developing, testing, mass producing, and shipping mRNA vaccines in record time. However, as the pandemic ebbs, the industry now ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Market Report 2025" has been added to ResearchAndMarkets.com's offering. The Nucleic Acid Therapeutics Global Market Report ...

With a long and established history in the marketplace, New England Biolabs ® (NEB ®) has been a key supplier in the biopharmaceutical industry for over 50 years. With a robust and reliable supply ...